These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20930295)

  • 1. Ultrafiltrate of blood plasma modulates amyloid-β aggregation.
    Nowicka A; Szczepankiewicz AA; Jaklewicz A; Filipek A; Barcikowska M; Elbaum D
    J Alzheimers Dis; 2011; 23(1):1-5. PubMed ID: 20930295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
    Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
    Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
    Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease.
    González-Martínez Á; Rosado B; Pesini P; Suárez ML; Santamarina G; García-Belenguer S; Villegas A; Monleón I; Sarasa M
    Exp Gerontol; 2011 Jul; 46(7):590-6. PubMed ID: 21377518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
    Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
    Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome.
    Coppus AM; Schuur M; Vergeer J; Janssens AC; Oostra BA; Verbeek MM; van Duijn CM
    Neurobiol Aging; 2012 Sep; 33(9):1988-94. PubMed ID: 21958962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
    Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
    Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome.
    Matsubara E; Ghiso J; Frangione B; Amari M; Tomidokoro Y; Ikeda Y; Harigaya Y; Okamoto K; Shoji M
    Ann Neurol; 1999 Apr; 45(4):537-41. PubMed ID: 10211483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.
    Xu W; Kawarabayashi T; Matsubara E; Deguchi K; Murakami T; Harigaya Y; Ikeda M; Amari M; Kuwano R; Abe K; Shoji M
    Brain Res; 2008 Jul; 1219():169-79. PubMed ID: 18534566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
    Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
    Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging.
    del Mar Hernandez M; Esteban M; Szabo P; Boada M; Unzeta M
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):183-7. PubMed ID: 15894424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.
    Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M
    J Alzheimers Dis; 2010; 21(1):81-6. PubMed ID: 20413863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.
    Güntert A; Campbell J; Saleem M; O'Brien DP; Thompson AJ; Byers HL; Ward MA; Lovestone S
    J Alzheimers Dis; 2010; 21(2):585-96. PubMed ID: 20571216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple Colorimetric Detection of Amyloid β-peptide (1-40) based on Aggregation of Gold Nanoparticles in the Presence of Copper Ions.
    Zhou Y; Dong H; Liu L; Xu M
    Small; 2015 May; 11(18):2144-9. PubMed ID: 25641831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophoretic separation of amyloid beta peptides in plasma.
    Lewczuk P; Esselmann H; Bibl M; Paul S; Svitek J; Miertschischk J; Meyrer R; Smirnov A; Maler JM; Klein C; Otto M; Bleich S; Sperling W; Kornhuber J; Rüther E; Wiltfang J
    Electrophoresis; 2004 Oct; 25(20):3336-43. PubMed ID: 15490456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease.
    Laske C; Stellos K; Stransky E; Leyhe T; Gawaz M
    J Alzheimers Dis; 2009; 17(1):115-23. PubMed ID: 19494436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum beta-amyloid correlates with neuropsychological impairment.
    Luis CA; Abdullah L; Paris D; Quadros A; Mullan M; Mouzon B; Ait-Ghezala G; Crawford F; Mullan M
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2009 Mar; 16(2):203-18. PubMed ID: 18923961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
    Buerger K; Frisoni G; Uspenskaya O; Ewers M; Zetterberg H; Geroldi C; Binetti G; Johannsen P; Rossini PM; Wahlund LO; Vellas B; Blennow K; Hampel H
    Exp Gerontol; 2009 Sep; 44(9):579-85. PubMed ID: 19539742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease.
    Kulstad JJ; Green PS; Cook DG; Watson GS; Reger MA; Baker LD; Plymate SR; Asthana S; Rhoads K; Mehta PD; Craft S
    Neurology; 2006 May; 66(10):1506-10. PubMed ID: 16717209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.